|
EAF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.304100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.610000E-02 |
| Normal-vs-Stage2 |
5.328600E-01 |
| Normal-vs-Stage3 |
5.020500E-04 |
| Normal-vs-Stage4 |
2.962200E-02 |
| Stage1-vs-Stage2 |
2.023000E-01 |
| Stage1-vs-Stage3 |
7.519700E-02 |
| Stage1-vs-Stage4 |
6.627800E-01 |
| Stage2-vs-Stage3 |
3.006300E-02 |
| Stage2-vs-Stage4 |
1.967770E-01 |
| Stage3-vs-Stage4 |
3.893200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.097300E-03 |
| Normal-vs-AfricanAmerican |
9.420400E-01 |
| Normal-vs-Asian |
6.523300E-03 |
| Caucasian-vs-AfricanAmerican |
4.859800E-02 |
| Caucasian-vs-Asian |
4.896400E-01 |
| AfricanAmerican-vs-Asian |
2.909900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.698800E-03 |
| Normal-vs-Female |
2.962100E-02 |
| Male-vs-Female |
1.883030E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.981600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.016000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.626280E-02 |
| Normal-vs-Age(81-100Yrs) |
3.734600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.459400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.851000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.426800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.903800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.566400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.117600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.023830E-02 |
| Classical-VS-Follicular |
7.380600E-01 |
| Classical-VS-Other |
8.109900E-02 |
| Classical-VS-Normal |
5.400400E-02 |
| Tall-VS-Follicular |
7.844400E-02 |
| Tall-VS-Other |
4.202200E-01 |
| Tall-VS-Normal |
1.259680E-03 |
| Follicular-VS-Other |
2.097400E-01 |
| Follicular-VS-Normal |
7.795700E-02 |
| Other-VS-Normal |
1.515970E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.402340E-02 |
| Normal-vs-N1 |
3.984700E-04 |
| N0-vs-N1 |
7.152200E-02 |
|
|
